InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by ElBardissi Andrew, Director. Director active across 1 company, notably Acutus Medical, Inc.. In total, 5 filings have been published. History available since 17 June 2021. The latest transaction was filed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Andrew ElBardissi is a Board Member at Acutus Medical, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and performance evaluation.